Navigation Links
Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems
Date:5/31/2008

WINSTON-SALEM, N.C. Adults who survived childhood Hodgkins Lymphoma should be especially vigilant about cancer and cardiovascular screenings, according to researchers from Wake Forest University Baptist Medical Center and colleagues.

Reporting at the annual meeting of the American Society of Clinical Oncology in Chicago today, Sharon Castellino, M.D., a pediatric oncologist, said a 26-center study of 1,927 Hodgkins survivors found that treatments for the disease are associated with increased risk of dying from a second cancer or cardiovascular disease.

The bottom-line message is that a portion of those who survive Hodgkins Lymphoma continue to have significant health needs beyond their five-year cure mark, said Castellino, an assistant professor of pediatrics at Brenner Childrens Hospital, part of Wake Forest Baptist. Survivors and their doctors need to be aware of continued risks in adulthood from treatment received more than 20 years ago.

Hodgkins Lymphoma is a growth of malignant cells in the lymph system, which is part of the immune system. The disease is one of the more curable cancers and was one of the first successes in the 1970s, said Castellino. Currently, Hodgkins Lymphoma has a 5-year survival rate of 90 percent.

The disease most commonly occurs in the chest and its treatment involves radiation therapy of the neck and upper chest and/or chemotherapy. The goal of the study was to look at factors that may increase the risk of premature death. It involved 1,927 adults who were diagnosed between 1970 and 1986 at a median age of 14 years. They were followed for a median of 23 years through the Childhood Cancer Survivor Study (CCSS).

There have been 320 deaths in the group with 30 percent due to recurrence, 26 percent to a second cancer and 19 percent to a cardiovascular event such as a heart attack or stroke.

Among males, increased risk of premature death was associated with higher doses of chemotherapy regimens that included anthracycline drugs. In female five-year survivors, all doses of radiation therapy were associated with a higher risk of premature death.

The development of second malignancies impacted survival in both sexes. In addition, a cardiovascular condition conferred a significant risk of death in male survivors.

It hadnt been clarified until this study that there was a different pattern of risks in men and women, said Castellino. Other than a recurrence of the original cancer, the leading cause of death in women is breast cancer and for men it is cardiovascular events.

Castellino said the findings about cardiovascular disease are especially disturbing because about 30 percent of study participants had smoked at some time. She said the findings could lead to prevention recommendations, such as earlier health screenings.

Currently, women who received treatment for the disease are advised to have mammograms as early as 25-years-old, she said. But, currently there are no specific guidelines for heart disease prevention over those for the general population.

Since the 1980s, radiation therapy doses have been lowered in children with the goal of successfully treating the disease without causing undue side effects from the treatment. However, Castellino said that even though radiation doses are lower and techniques are refined, the heart and other critical structures are often exposed to radiation.

Castellino is continuing the research by working to learn more about what changes occur as a result of radiation and identifying ways to intervene possibly with drugs before the damage is done.


'/>"/>

Contact: Rae Bush
rbush@wfubmc.edu
336-716-6878
Wake Forest University Baptist Medical Center
Source:Eurekalert

Related medicine news :

1. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
2. New York City Cancer Patients, Survivors and Care Givers Encouraged to Keep Going(R)
3. Chemotherapy may be culprit for fatigue in breast cancer survivors
4. Long-Term Fatigue Plagues Cancer Survivors
5. ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship
6. Breast cancer survivors optimistic, yet lack critical information on reducing recurrence
7. Heart Attack Survivors Benefit From Rehab
8. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
9. New Software Program Helps Breast Cancer Survivors and Patients Fight Chemofog
10. Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa
11. Breast Cancer Survivors Treated to a Day of Luxury for Breast Cancer Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... 19, 2017 , ... Curl Keeper® is excited to announce that the H2O ... 2017 Award for the second year in a row. The H2O Bottle, a refillable ... voted Best Moisturizer for Type 2 Wavies and Best Refresher for Type 2 Wavies ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... has joined its Orlando location as an interventional pain management physician. He brings ... on the treatment of migraine headaches, and significant experience in spinal cord stimulation ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... Immediate Release                Contact: Julian Teixeira, August 18, 2017                    202-478-8564 / jteixeira@thenc.org , ... from their Fathers , Contrary to a father’s perception, ...
(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... asset protection assistance to communities in North-Central West Virginia, is embarking on a ... at-risk boys in the area. , The Chestnut Mountain Ranch (CMR) is a ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, Inc. ... today announced that its Board of Directors has approved the ... third quarter of 2017. ... on or about October 27, 2017 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
(Date:8/7/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent ... 30, 2017.  All comparisons, unless otherwise noted, are to the ... Second Quarter 2017 Highlights include: ... increase of 3.5% Total prescriptions dispensed of ... 7.5% versus 7.6% Gross profit per ...
Breaking Medicine Technology: